Pharmaceuticals company Orchid Pharma announced Q2FY26 results Sales: Rs 194 crore against Rs 223 crore during Q2FY25, change -13%. EBITDA: Rs 15 crore against Rs 38 crore during Q2FY25, change -61%. PBT: Rs 2 crore against Rs 26 crore during Q2FY25, change -92%. PAT: Rs 2 crore against Rs 26 crore during Q2FY25, change -92%. Result PDF